
Voyager Therapeutics, Inc.
VYGR·NASDAQ
Last updated as of 2026-06-25 19:16 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
VYGR stock price change
On the last trading day, VYGR stock closed at 3.65 USD, with a price change of -0.68% for the day.
Trade spot stocks (24/7)Trending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreVYGR key data
Previous close3.65 USD
Market cap220.84M USD
Volume299.21K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-1.98 USD
Net income (FY)−119.72M USD
Revenue (FY)40.37M USD
Next report dateJul 30, 2026
EPS estimate-
Revenue estimate5.59M USD USD
Shares float50.38M
Beta (1Y)0.84

Voyager Therapeutics, Inc. overview
Sector
Health technology
Industry
Biotechnology
CEO
Alfred W. Sandrock
Headquarters
Lexington
Website
voyagertherapeutics.com
Founded
2013
Employees (FY)
141
Change (1Y)
−31 −18.02%
Revenue / Employee (1Y)
286.34K USD
Net income / Employee (1Y)
−849.09K USD
VYGR stock price forecast
According to technical indicators for VYGR stock, the price is likely to fluctuate within the range of 4.10–4.78 USD over the next week. Market analysts predict that the price of VYGR stock will likely fluctuate within the range of 3.59–4.97 USD over the next months.
Based on 1-year price forecasts from 30 analysts, the highest estimate is 12.11 USD, while the lowest estimate is 3.29 USD.
For more information, please see the
VYGR stock price forecast
page.
Latest VYGR stock news
Voyager's Starlab (VOYG) Customer Wins Signal Early Demand For Post-ISS Commercial Manufacturing in Low-Earth Orbit
Finviz2026-03-04 17:30:46
Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
Finviz2026-03-05 23:33:48
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
Gene therapy pioneer Voyager Therapeutics Inc (stock code: VYGR) announced that by the end of fiscal year 2025, the company held strong cash and cash equivalents totaling $202 million.
老虎证券2026-03-09 20:24:08
Oracle, Ulta, Adobe, More Stocks With Earnings This Week
Finviz2026-03-09 20:23:00
Voyager Technologies Stock Surges After Q4 EPS Beat
Finviz2026-03-10 19:18:45
Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG
Finviz2026-03-11 10:03:49
Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG
Finviz2026-03-11 10:03:49
Voyager Acquisition Corporation has officially disclosed the results of the share redemption related to its business merger with Veraxa Biotech Ag.
老虎证券2026-03-11 10:23:31
Voyager Acquisition Corp II has officially submitted an application, planning to list its trading units on the Nasdaq Global Market.
老虎证券2026-03-13 10:14:35
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Finviz2026-03-18 12:06:10
Chrysler Redefined: 2027 Pacifica Leads With Modern New Aesthetic and Proven Family-friendly Features
Finviz2026-04-01 15:12:50
FCA US First-quarter Sales Increase 4% Year Over Year
Finviz2026-04-01 17:39:58